International Assets Investment Management LLC increased its stake in Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 4,856.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 38,062 shares of the business services provider's stock after purchasing an additional 37,294 shares during the quarter. International Assets Investment Management LLC's holdings in Stericycle were worth $1,886,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Strategic Blueprint LLC lifted its stake in Stericycle by 6.2% in the 4th quarter. Strategic Blueprint LLC now owns 5,609 shares of the business services provider's stock worth $278,000 after purchasing an additional 326 shares in the last quarter. Equitable Trust Co. raised its position in shares of Stericycle by 7.1% in the fourth quarter. Equitable Trust Co. now owns 7,120 shares of the business services provider's stock worth $353,000 after buying an additional 473 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Stericycle by 9.0% during the fourth quarter. Nisa Investment Advisors LLC now owns 7,269 shares of the business services provider's stock valued at $360,000 after buying an additional 600 shares during the period. Fifth Third Bancorp grew its position in Stericycle by 3.2% during the fourth quarter. Fifth Third Bancorp now owns 50,824 shares of the business services provider's stock worth $2,519,000 after buying an additional 1,561 shares in the last quarter. Finally, Blue Trust Inc. increased its stake in Stericycle by 15.4% in the 4th quarter. Blue Trust Inc. now owns 3,125 shares of the business services provider's stock worth $155,000 after acquiring an additional 416 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on SRCL shares. Truist Financial dropped their price target on Stericycle from $57.00 to $50.00 and set a "hold" rating for the company in a research report on Monday, April 29th. Wells Fargo & Company boosted their price target on shares of Stericycle from $40.00 to $48.00 and gave the stock an "underweight" rating in a research note on Friday, March 1st. StockNews.com cut shares of Stericycle from a "buy" rating to a "hold" rating in a research report on Tuesday, April 2nd. Stifel Nicolaus upped their target price on shares of Stericycle from $70.00 to $75.00 and gave the stock a "buy" rating in a research report on Thursday, February 29th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $69.00 price target on shares of Stericycle in a research note on Thursday, March 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $59.40.
Check Out Our Latest Report on SRCL
Stericycle Trading Down 1.0 %
NASDAQ:SRCL traded down $0.47 during trading hours on Monday, reaching $46.47. The company's stock had a trading volume of 217,943 shares, compared to its average volume of 465,582. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market capitalization of $4.31 billion, a price-to-earnings ratio of -215.09, a PEG ratio of 2.53 and a beta of 1.12. The firm has a 50-day simple moving average of $50.31 and a 200-day simple moving average of $48.55. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $57.06.
Stericycle (NASDAQ:SRCL - Get Free Report) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analysts' expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company's revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period last year, the firm earned $0.49 earnings per share. Research analysts expect that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.
Stericycle Company Profile
(
Free Report)
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Further Reading
Before you consider Stericycle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.
While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
